Baltimore, MD, United States of America

Harry Quigley

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Johns Hopkins University. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry Quigley. Retrieved from https://idiyas.com/inventor/harry-quigley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Harry Quigley in Neurodegenerative Disease Treatment

Introduction

Harry Quigley is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of neurodegenerative disease treatment. With a total of 2 patents, his work focuses on developing innovative solutions for conditions related to neurodegeneration and ocular diseases.

Latest Patents

Quigley's latest patents include compositions and methods for the treatment of neurodegenerative diseases. These patents disclose compounds, compositions, kits, and methods aimed at treating conditions associated with neurodegeneration or ocular disease. His research is pivotal in advancing therapeutic options for patients suffering from these debilitating conditions.

Career Highlights

Harry Quigley is affiliated with The Johns Hopkins University, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on the treatment of neurodegenerative diseases. Quigley's dedication to innovation in this field is evident through his patent filings and ongoing research efforts.

Collaborations

Some of his notable coworkers include Donald Jeffrey Zack and Zhiyong Yang. Their collaborative efforts contribute to the advancement of research in neurodegenerative diseases and enhance the potential for innovative treatments.

Conclusion

Harry Quigley's contributions to the field of neurodegenerative disease treatment through his patents and research at The Johns Hopkins University highlight his role as a key innovator. His work continues to inspire advancements in medical science and offers hope for improved therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…